Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine

Retina Today – October 2014
By Pravin U. Dugel, M.D.

Leading retinal specialist and industry opinion leader Pravin U. Dugel, MD, discusses ONL Therapeutics’ core technology and its significant potential to treat retinal disease.

Read the Article

Privacy Statement | Accessibility Statement | Terms of Use | Copyright All Rights Reserved ©2024